Evidence map›Paper›PMID 39903121›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieu.

Caroline Boulouis, Elli Mouchtaridi, Thomas R Müller, Jeffrey Y W Mak, David P Fairlie, Peter Bergman, Jakob Michaëlsson, Jonas Halfvarson, Jenny Mjösberg, Marcus Buggert and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Caroline BoulouisCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0000-0003-0562-5395
Elli MouchtaridiCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0009-0005-4154-9010
Thomas R MüllerCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Jeffrey Y W MakCentre for Chemistry and Drug Discovery, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia.ORCID 0000-0002-8011-4539
David P FairlieCentre for Chemistry and Drug Discovery, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia.ORCID 0000-0002-7856-8566
Peter BergmanDepartment of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0000-0003-3306-3713
Jakob MichaëlssonCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Jonas HalfvarsonDepartment of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro 70182, Sweden.ORCID 0000-0003-0122-7234
Jenny MjösbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Marcus BuggertCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0000-0003-0633-1719
Johan K SandbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0000-0002-6275-0750

Funding

Investigating the basis of MAIT cell antigen potencyR01AI148407 · NIAID · UNIVERSITY OF MELBOURNE · PI MCCLUSKEY, JAMES · 2020 to 2024
$2.7M
Cancerfonden (Swedish Cancer Society) 20-1142PjFCancerfonden (Swedish Cancer Society) 23-2912PjDeutsche Forschungsgemeinschaft (DFG) 496946670DHAC | National Health and Medical Research Council (NHMRC) 2009551HHS | National Institutes of Health (NIH) AI148407Hjärt-Lungfonden (Swedish Heart-Lung Foundation) 2021044722Hjärt-Lungfonden (Swedish Heart-Lung Foundation) 20230551KI | Center for Innovative Medicine (CIMED) FoUI-989096NIAID NIH HHS R01 AI148407Vetenskapsrådet (VR) 2020-01743Vetenskapsrådet (VR) 2023-02857
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are unconventional T cells that mediate rapid antimicrobial immune responses to antigens derived from microbial riboflavin pathway metabolites presented by the evolutionarily conserved MR1 molecules. MAIT cells represent a large pre-expanded T cell subset in humans and are involved in both protective immunity and inflammatory immunopathology. However, what controls the functional heterogeneity of human MAIT cell responses is still largely unclear. Here, combining functional and transcriptomic analyses, we investigate how MAIT cell response programs are influenced by the cytokine milieu at the time of antigen recognition. Activation by MR1-presented antigen together with IL-12 induces intermediate levels of IFNγ and TNF, as well as a regulatory profile with substantial IL-10 production and elevated expression of TIM-3, LAG-3, and PD-1. Activation by the combination of antigen and IL-12 induces a c-MAF-dependent program required for IL-10 production. The MAIT cell-derived IL-10 mediates both autocrine and paracrine immune regulation. In contrast, coactivation of MAIT cells with IL-18 induces IL-17, GM-CSF, IFNγ, and TNF, without IL-10. Notably, IL-18 dominantly counteracts IL-10 expression. The activation states biased toward IL-10 or IL-17 production are reversible and do not represent stable subsets. Finally, MR1-restricted TCR-mediated activation without cytokine coactivation drives primarily granzyme B cytolytic arming. Altogether, these findings demonstrate that human MAIT cells adapt their functional effector response during antigen recognition to cytokine cues in the microenvironment, and identify programs biased toward either regulatory c-MAF-dependent IL-10 expression, or an inflammatory IL-17 and GM-CSF profile.

Indexed as

CytokinesInterleukin-10Interleukin-17Mucosal-Associated Invariant T CellsGranzymesHepatitis A Virus Cellular Receptor 2Histocompatibility Antigens Class IHumansInterferon-gammaInterleukin-12Lymphocyte ActivationMinor Histocompatibility AntigensTumor Necrosis Factor-alphaCytokinesGranzymesHepatitis A Virus Cellular Receptor 2Histocompatibility Antigens Class IIL10 protein, humanInterferon-gammaInterleukin-10Interleukin-12Interleukin-17Minor Histocompatibility AntigensMR1 protein, humanTumor Necrosis Factor-alphahumanIL-10MAIT cellsMR1T cells

Identifiers

PMID39903121
PMCPMC11831165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.